Calisici Erhan, Eras Zeynep, Oncel Mehmet Yekta, Oguz Serife Suna, Gokce İsmail Kursat, Dilmen Ugur
a Division of Neonatology , Zekai Tahir Burak Maternity Teaching Hospital , Ankara , Turkey and.
b Division of Neonatology , Yıldırım Beyazıt University , Ankara , Turkey.
J Matern Fetal Neonatal Med. 2015;28(17):2115-20. doi: 10.3109/14767058.2014.979783. Epub 2014 Nov 14.
Our objective was to determine the neurodevelopmental outcome at 18-24 months' of corrected age (CA) in preterm infants with severe intraventricular hemorrhage (IVH).
This was a retrospective cohort study of all preterm infants who were <37 weeks' gestation, had Grade 3-4 IVH, were admitted between January 2009 and December 2010 and discharged. The cohort was divided into three groups. Group 1 was defined as infants born with a birth weight (BW) less than 1000 g, group 2 was defined as infants born with a BW between 1000 and 1500 g and group 3 was defined as infants born with a BW between 1501 and 2500 g. Severe IVH was defined as the presence of grade 3-4 IVH on cranial ultrasound. Cranial ultrasound was performed in the first week of life and subsequently at weekly intervals by a radiologist. A comprehensive assessment including hearing, vision, neurological and developmental evaluation with Bayley Scales of Infant Development, Second edition was performed by the experienced researchers at 18-24 months' CA. Neurodevelopmental impairment (NDI) was defined as at the presence of one or more of the following: cerebral palsy; Mental Developmental Index score lower than 70; Psychomotor Developmental Index score lower than 70; bilateral hearing impairment; or bilateral blindness.
From January 2009 to December 2010, a total of 138 infants were diagnosed as severe IVH (grade 3-4). Of them, 74 (71.1%) infants (group 1 = 31, group 2 = 29 and group 3 = 14 infants) completed the follow-up visit and evaluated at 18-24 months' CA. Median Apgar score (p < 0.01) and resuscitation at birth (p < 0.01) were significantly different for groups 1-3. The use of catheterization, need for mechanical ventilation, need for phototherapy, retinopathy of premature and bronchopulmonary dysplasia were significantly higher in group 1 compared to groups 2 and 3 (p < 0.001, p < 0.001, p < 0.01, p < 0.01 and p = 0.014, respectively). The duration of hospitalization and mortality rates consistent with the degree of prematurity were significantly higher in group 1 compared to groups 2 and 3 (p = 0.03 and p = 0.01). Among the long-term outcomes, the rates of CP and NDI did not differ between the groups (p = 0.68 and p = 0.068).
Our results demonstrated that long-term outcomes of preterm infants did not differ between the groups classified according to the BW at two years of age. This has leaded to the conclusion that severe IVH is alone represents a significant risk factor for poor neurodevelopmental outcome in this already high-risk population.
我们的目的是确定重度脑室内出血(IVH)的早产儿在矫正年龄(CA)18 - 24个月时的神经发育结局。
这是一项对所有孕周小于37周、患有3 - 4级IVH、于2009年1月至2010年12月期间入院并出院的早产儿进行的回顾性队列研究。该队列分为三组。第1组定义为出生体重(BW)小于1000g的婴儿,第2组定义为出生体重在1000至1500g之间的婴儿,第3组定义为出生体重在1501至2500g之间的婴儿。重度IVH定义为头颅超声显示存在3 - 4级IVH。在出生后第一周进行头颅超声检查,随后由放射科医生每周进行一次检查。由经验丰富的研究人员在矫正年龄18 - 24个月时进行全面评估,包括听力、视力、神经学和使用贝利婴儿发展量表第二版进行的发育评估。神经发育障碍(NDI)定义为存在以下一种或多种情况:脑瘫;精神发育指数得分低于70;心理运动发育指数得分低于70;双侧听力障碍;或双侧失明。
2009年1月至2010年12月,共有138例婴儿被诊断为重度IVH(3 - 4级)。其中,74例(71.1%)婴儿(第1组 = 31例,第2组 = 29例,第3组 = 14例婴儿)完成了随访并在矫正年龄18 - 24个月时接受评估。第1 - 3组的中位阿氏评分(p < 0.01)和出生时复苏情况(p < 0.01)存在显著差异。与第2组和第3组相比,第1组的导尿术使用、机械通气需求、光疗需求、早产儿视网膜病变和支气管肺发育不良发生率显著更高(分别为p < 0.001、p < 0.001、p < 0.01、p < 0.01和p = 0.014)。与第2组和第3组相比,第1组的住院时间和与早产程度一致的死亡率显著更高(p = 0.03和p = 0.01)。在长期结局方面,各组之间的脑瘫和NDI发生率无差异(p = 0.68和p = 0.068)。
我们的结果表明,根据出生体重分类的各组早产儿在两岁时的长期结局无差异。由此得出结论,在这个本已高危的人群中,重度IVH单独代表了神经发育不良结局的一个重要危险因素。